September 06, 2026 article Pan-PPAR agonists: Emerging therapeutic strategies for metabolic dysfunction-associated steatotic liver disease Metabolism DOI: 10.1016/j.metabol.2026.156767 OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 0 References 2 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages☆ 2020 Journal of Hepatology article Medicine Liver Disease Diagnosis and Treatment Open access cited by 2 patents 315 citations Pharmacological treatment options for metabolic dysfunction‐associated steatotic liver disease in patients with type 2 diabetes mellitus: A systematic review 2025 European Journal of Clinical Investigation review Medicine Liver Disease Diagnosis and Treatment Open access 25 citations 2 results